Birth Outcomes in Women Who Have Taken Leflunomide During Pregnancy

OBJECTIVE: In preclinical reproductive studies, leflunomide was found to be embryotoxic and teratogenic. Women treated with leflunomide are advised to avoid pregnancy; those who become pregnant are advised to reduce fetal exposure through a cholestyramine drug elimination procedure. The present stud...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chambers, Christina D., Johnson, Diana L., Robinson, Luther K., Braddock, Stephen R., Xu, Ronghui, Lopez-Jimenez, Janina, Mirrasoul, Nicole, Salas, Elizabeth, Luo, Yunjun J., Jin, Shelia, Jones, Kenneth Lyons
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3633589/
https://ncbi.nlm.nih.gov/pubmed/20131283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.27358
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados